Industry: Chemical & Material
Published Date: 2025-06-19
Pages: 80 Pages
Report ld: 4769670
Request Sample
Customized Report
Pharmaceutical-grade HFA-134a Market Size(US$)

CAGR 2025-2031
7.1%
Market Size,2031
USD 1,316
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical-grade HFA-134a was valued at US$ 823 million in the year 2024 and is projected to reach a revised size of US$ 1316 million by 2031, growing at a CAGR of 7.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical-grade HFA-134a competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Pharmaceutical grade HFA-134a (1,1,1,2-tetrafluoroethane) is a high-purity aerosol propellant specifically designed for inhaled drug delivery systems (such as metered-dose inhalers for the treatment of asthma and chronic obstructive pulmonary disease). Its purity must comply with the standards of the United States Pharmacopoeia (USP) or the European Pharmacopoeia (EP), usually requiring ≥99.97%, and strictly controlling moisture, acidic impurities and non-volatile residues to ensure safety and compatibility. As an ozone-friendly alternative, it has gradually replaced traditional CFC propellants.
North American market for Pharmaceutical-grade HFA-134a is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical-grade HFA-134a is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pharmaceutical-grade HFA-134a include SRF, Koura, Juhua shares, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical-grade HFA-134a, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical-grade HFA-134a.
The Pharmaceutical-grade HFA-134a market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical-grade HFA-134a market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical-grade HFA-134a manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
SRF
Koura
Juhua shares
Segment by Type
99.99%
>99.99%
Segment
Segment
Segment
Segment by Application
Inhalation Aerosols
Topical Sprays
Others
Production by Region
North America
Europe
China
Japan
India
Southeast Asia
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical-grade HFA-134a manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical-grade HFA-134a by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical-grade HFA-134a in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Pharmaceutical-grade HFA-134a Market Overview
1.1 Product Definition
1.2 Pharmaceutical-grade HFA-134a by Type
1.2.1 Global Pharmaceutical-grade HFA-134a Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 99.99%
1.2.3 >99.99%
1.3 Pharmaceutical-grade HFA-134a by Application
1.3.1 Global Pharmaceutical-grade HFA-134a Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Inhalation Aerosols
1.3.3 Topical Sprays
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical-grade HFA-134a Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharmaceutical-grade HFA-134a Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharmaceutical-grade HFA-134a Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharmaceutical-grade HFA-134a Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical-grade HFA-134a Production Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical-grade HFA-134a Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharmaceutical-grade HFA-134a, Industry Ranking, 2023 VS 2024
2.4 Global Pharmaceutical-grade HFA-134a Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical-grade HFA-134a Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharmaceutical-grade HFA-134a, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical-grade HFA-134a, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical-grade HFA-134a, Date of Enter into This Industry
2.9 Pharmaceutical-grade HFA-134a Market Competitive Situation and Trends
2.9.1 Pharmaceutical-grade HFA-134a Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical-grade HFA-134a Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical-grade HFA-134a Production by Region
3.1 Global Pharmaceutical-grade HFA-134a Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharmaceutical-grade HFA-134a Production Value by Region (2020-2031)
3.2.1 Global Pharmaceutical-grade HFA-134a Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharmaceutical-grade HFA-134a by Region (2026-2031)
3.3 Global Pharmaceutical-grade HFA-134a Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharmaceutical-grade HFA-134a Production Volume by Region (2020-2031)
3.4.1 Global Pharmaceutical-grade HFA-134a Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharmaceutical-grade HFA-134a by Region (2026-2031)
3.5 Global Pharmaceutical-grade HFA-134a Market Price Analysis by Region (2020-2025)
3.6 Global Pharmaceutical-grade HFA-134a Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical-grade HFA-134a Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharmaceutical-grade HFA-134a Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharmaceutical-grade HFA-134a Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharmaceutical-grade HFA-134a Production Value Estimates and Forecasts (2020-2031)
3.6.5 India Pharmaceutical-grade HFA-134a Production Value Estimates and Forecasts (2020-2031)
3.6.6 Southeast Asia Pharmaceutical-grade HFA-134a Production Value Estimates and Forecasts (2020-2031)
4 Pharmaceutical-grade HFA-134a Consumption by Region
4.1 Global Pharmaceutical-grade HFA-134a Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharmaceutical-grade HFA-134a Consumption by Region (2020-2031)
4.2.1 Global Pharmaceutical-grade HFA-134a Consumption by Region (2020-2025)
4.2.2 Global Pharmaceutical-grade HFA-134a Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharmaceutical-grade HFA-134a Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharmaceutical-grade HFA-134a Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical-grade HFA-134a Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharmaceutical-grade HFA-134a Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical-grade HFA-134a Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharmaceutical-grade HFA-134a Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical-grade HFA-134a Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharmaceutical-grade HFA-134a Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical-grade HFA-134a Production by Type (2020-2031)
5.1.1 Global Pharmaceutical-grade HFA-134a Production by Type (2020-2025)
5.1.2 Global Pharmaceutical-grade HFA-134a Production by Type (2026-2031)
5.1.3 Global Pharmaceutical-grade HFA-134a Production Market Share by Type (2020-2031)
5.2 Global Pharmaceutical-grade HFA-134a Production Value by Type (2020-2031)
5.2.1 Global Pharmaceutical-grade HFA-134a Production Value by Type (2020-2025)
5.2.2 Global Pharmaceutical-grade HFA-134a Production Value by Type (2026-2031)
5.2.3 Global Pharmaceutical-grade HFA-134a Production Value Market Share by Type (2020-2031)
5.3 Global Pharmaceutical-grade HFA-134a Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pharmaceutical-grade HFA-134a Production by Application (2020-2031)
6.1.1 Global Pharmaceutical-grade HFA-134a Production by Application (2020-2025)
6.1.2 Global Pharmaceutical-grade HFA-134a Production by Application (2026-2031)
6.1.3 Global Pharmaceutical-grade HFA-134a Production Market Share by Application (2020-2031)
6.2 Global Pharmaceutical-grade HFA-134a Production Value by Application (2020-2031)
6.2.1 Global Pharmaceutical-grade HFA-134a Production Value by Application (2020-2025)
6.2.2 Global Pharmaceutical-grade HFA-134a Production Value by Application (2026-2031)
6.2.3 Global Pharmaceutical-grade HFA-134a Production Value Market Share by Application (2020-2031)
6.3 Global Pharmaceutical-grade HFA-134a Price by Application (2020-2031)
7 Key Companies Profiled
7.1 SRF
7.1.1 SRF Pharmaceutical-grade HFA-134a Company Information
7.1.2 SRF Pharmaceutical-grade HFA-134a Product Portfolio
7.1.3 SRF Pharmaceutical-grade HFA-134a Production, Value, Price and Gross Margin (2020-2025)
7.1.4 SRF Main Business and Markets Served
7.1.5 SRF Recent Developments/Updates
7.2 Koura
7.2.1 Koura Pharmaceutical-grade HFA-134a Company Information
7.2.2 Koura Pharmaceutical-grade HFA-134a Product Portfolio
7.2.3 Koura Pharmaceutical-grade HFA-134a Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Koura Main Business and Markets Served
7.2.5 Koura Recent Developments/Updates
7.3 Juhua shares
7.3.1 Juhua shares Pharmaceutical-grade HFA-134a Company Information
7.3.2 Juhua shares Pharmaceutical-grade HFA-134a Product Portfolio
7.3.3 Juhua shares Pharmaceutical-grade HFA-134a Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Juhua shares Main Business and Markets Served
7.3.5 Juhua shares Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical-grade HFA-134a Industry Chain Analysis
8.2 Pharmaceutical-grade HFA-134a Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical-grade HFA-134a Production Mode & Process Analysis
8.4 Pharmaceutical-grade HFA-134a Sales and Marketing
8.4.1 Pharmaceutical-grade HFA-134a Sales Channels
8.4.2 Pharmaceutical-grade HFA-134a Distributors
8.5 Pharmaceutical-grade HFA-134a Customer Analysis
9 Pharmaceutical-grade HFA-134a Market Dynamics
9.1 Pharmaceutical-grade HFA-134a Industry Trends
9.2 Pharmaceutical-grade HFA-134a Market Drivers
9.3 Pharmaceutical-grade HFA-134a Market Challenges
9.4 Pharmaceutical-grade HFA-134a Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical-grade HFA-134a market is projected to grow from US$ 872 million in 2025 to US$ 1400 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 121
USD 4900.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market size was US$ 872 million in 2025 and is forecast to reach a readjusted size of US$ 1400 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 72
USD 4250.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market was valued at US$ 872 million in 2025 and is anticipated to reach US$ 1400 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 125
USD 2900.00
(Single User License)
The global market for Pharmaceutical-grade HFA-134a was estimated to be worth US$ 872 million in 2025 and is projected to reach US$ 1400 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 83
USD 3950.00
(Single User License)
The global market for Pharmaceutical-grade HFA-134a was estimated to be worth US$ 823 million in 2024 and is forecast to a readjusted size of US$ 1316 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-06-19
Pages: 85
USD 3950.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market size was US$ 823 million in 2024 and is forecast to a readjusted size of US$ 1316 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-06-19
Pages: 69
USD 4250.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market is projected to grow from US$ 872 million in 2025 to US$ 1316 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period.
Published Date: 2025-06-19
Pages: 116
USD 4900.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market is projected to grow from US$ 872 million in 2025 to US$ 1400 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 121
The global Pharmaceutical-grade HFA-134a market size was US$ 872 million in 2025 and is forecast to reach a readjusted size of US$ 1400 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 72
The global Pharmaceutical-grade HFA-134a market was valued at US$ 872 million in 2025 and is anticipated to reach US$ 1400 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-12
Pages: 125
The global market for Pharmaceutical-grade HFA-134a was estimated to be worth US$ 872 million in 2025 and is projected to reach US$ 1400 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-09
Pages: 83
The global market for Pharmaceutical-grade HFA-134a was estimated to be worth US$ 823 million in 2024 and is forecast to a readjusted size of US$ 1316 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-06-19
Pages: 85
The global Pharmaceutical-grade HFA-134a market size was US$ 823 million in 2024 and is forecast to a readjusted size of US$ 1316 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-06-19
Pages: 69
The global Pharmaceutical-grade HFA-134a market is projected to grow from US$ 872 million in 2025 to US$ 1316 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period.
Published: 2025-06-19
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now